(Q35593254)

English

Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy

scientific article published on June 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy (English)

1 reference

Europe PubMed Central

9 August 2017

0 references

author name string

M Yokoi

1

1 reference

Europe PubMed Central

9 August 2017

S-I Yamagishi

2

1 reference

Europe PubMed Central

9 August 2017

M Takeuchi

3

1 reference

Europe PubMed Central

9 August 2017

K Ohgami

4

1 reference

Europe PubMed Central

9 August 2017

T Okamoto

5

1 reference

Europe PubMed Central

9 August 2017

W Saito

6

1 reference

Europe PubMed Central

9 August 2017

M Muramatsu

7

1 reference

Europe PubMed Central

9 August 2017

T Imaizumi

8

1 reference

Europe PubMed Central

9 August 2017

S Ohno

9

1 reference

Europe PubMed Central

9 August 2017

language of work or name

0 references

publication date

1 June 2005

1 reference

Europe PubMed Central

9 August 2017

British Journal of Ophthalmology

1 reference

Europe PubMed Central

9 August 2017

89

1 reference

Europe PubMed Central

9 August 2017

6

1 reference

Europe PubMed Central

9 August 2017

673-675

1 reference

Europe PubMed Central

9 August 2017

Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772676

27 July 2018

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772676

27 July 2018

Therapeutic potential of anti-oxidants and diabetic retinopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772676

27 July 2018

Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772676

27 July 2018

The National Diabetic Retinopathy Laser Treatment Audit. III. Clinical outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772676

27 July 2018

Advanced glycation end products increase retinal vascular endothelial growth factor expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772676

27 July 2018

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772676

27 July 2018

Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772676

26 September 2018

Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772676

26 September 2018

Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772676

26 September 2018

Glycation and inactivation of human Cu-Zn-superoxide dismutase. Identification of the in vitro glycated sites

1 reference

https://pubmed.ncbi.nlm.nih.gov/15923499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15923499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15923499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BJO.2004.055053

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35593254&oldid=1580745915"